Tom Coenye Selected Research

Tom Coenye Research Topics

Disease

48	Infections 12/2023 - 01/2010
19	Cystic Fibrosis (Mucoviscidosis) 04/2024 - 04/2002
10	Wounds and Injuries (Trauma) 12/2023 - 01/2013
5	Starvation 01/2020 - 09/2008
3	Communicable Diseases (Infectious Diseases) 11/2023 - 01/2017
3	Pseudomonas Infections 11/2023 - 02/2015
3	Acne Vulgaris 01/2022 - 05/2007
2	Persistent Infection 10/2022 - 01/2019
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022 - 09/2021
2	Rhinosinusitis 06/2021 - 11/2008
2	Surgical Wound 01/2017 - 01/2017
1	Inborn Genetic Diseases (Disease, Hereditary) 04/2024
1	Hypersensitivity (Allergy) 11/2023
1	Hypoxia (Hypoxemia) 12/2022
1	Respiratory Insufficiency (Respiratory Failure) 12/2022
1	Bronchiectasis 01/2022
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Hair Diseases 01/2022
1	Chronic Disease (Chronic Diseases) 01/2022
1	Atopic Dermatitis (Atopic Eczema) 01/2022
1	Skin Diseases (Skin Disease) 01/2022
1	Lung Diseases (Lung Disease) 09/2021
1	Hemolysis 07/2020
1	Pressure Ulcer (Bedsore) 07/2020
1	Candidemia 01/2020
1	Wound Infection (Wound Infections) 01/2018

Drug/Important Bio-Agent (IBA)

27	Anti-Bacterial Agents (Antibiotics)IBA 12/2023 - 09/2008
6	IronIBA 01/2020 - 01/2010
5	Proteins (Proteins, Gene)FDA Link 07/2020 - 06/2002
5	Peptide Hydrolases (Proteases)FDA Link 02/2018 - 09/2008
5	Anti-Infective Agents (Microbicides)IBA 01/2015 - 05/2007
4	Tobramycin (Nebcin)FDA LinkGeneric 01/2021 - 09/2013
4	Virulence Factors (Pathogenicity Factors)IBA 02/2018 - 05/2007
4	Ribosomal DNA (rDNA)IBA 09/2003 - 04/2002
3	resazurinIBA 12/2023 - 07/2017
3	Vancomycin FDA LinkGeneric 02/2017 - 10/2016
3	GalliumIBA 01/2017 - 01/2017
2	SolutionsIBA 11/2023 - 01/2017
2	Ciprofloxacin (Cipro)FDA LinkGeneric 11/2023 - 01/2017
2	SilverIBA 11/2023 - 07/2017
2	AlginatesIBA 11/2023 - 10/2015
2	fosmidomycinIBA 09/2023 - 09/2011
2	LigandsIBA 01/2022 - 02/2017
2	colloidal silverIBA 06/2021 - 07/2017
2	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2018
2	Peptides (Polypeptides)IBA 01/2019 - 02/2015
2	hamamelitanninIBA 02/2017 - 10/2016
2	DeferiproneIBA 01/2017 - 01/2017
2	butyl phosphorotrithioate (DEF)IBA 01/2017 - 01/2017
2	protoporphyrin IXIBA 01/2017 - 01/2017
2	Chelating AgentsIBA 01/2017 - 01/2017
2	EnzymesIBA 01/2017 - 09/2011
2	Heme (Haem)IBA 01/2017 - 01/2017
2	Fatty Acids (Saturated Fatty Acids)IBA 09/2003 - 06/2002
2	DNA (Deoxyribonucleic Acid)IBA 07/2003 - 06/2002
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 04/2024
1	Gentamicins (Gentamicin)FDA LinkGeneric 12/2023
1	Liposomes (Liposome)IBA 12/2023
1	malic acid (malate)IBA 11/2023
1	PolymersIBA 11/2023
1	poly(lactide) (polylactic acid)IBA 11/2023
1	acrylic acid (acrylate)IBA 11/2023
1	Carboxymethylcellulose Sodium (Polycell)FDA Link 11/2023
1	IodineIBA 11/2023
1	Pyrrolidinones (Pyrrolidones)IBA 11/2023
1	Urethane (Ethyl Carbamate)IBA 11/2023
1	Ethylene Glycol (Monoethylene Glycol)IBA 11/2023
1	HydrogelsIBA 11/2023
1	isoborneol (borneol)IBA 10/2022
1	PhytochemicalsIBA 10/2022
1	citral (neral)IBA 10/2022
1	EmulsionsIBA 10/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022
1	LipidsIBA 01/2022
1	LipopolysaccharidesIBA 01/2022
1	Matrix Metalloproteinases (MMPs)IBA 01/2022
1	EndocannabinoidsIBA 01/2022
1	NeuropeptidesIBA 01/2022
1	Pattern Recognition ReceptorsIBA 01/2022
1	InterleukinsIBA 01/2022
1	SteroidsIBA 01/2022
1	SaltsIBA 01/2022
1	AcidsIBA 01/2022
1	TitaniumIBA 02/2021
1	AminoglycosidesIBA 01/2021
1	CytosineIBA 01/2021
1	furanone C-30IBA 01/2021
1	Ointments (Pastes)IBA 12/2020
1	PlasticsIBA 07/2020
1	Fluconazole (Zonal)FDA LinkGeneric 01/2020
1	Piperacillin FDA LinkGeneric 01/2020
1	AzolesIBA 01/2020
1	Zonula Occludens-1 ProteinIBA 01/2020
1	Acyl-ButyrolactonesIBA 01/2020
1	Antimicrobial PeptidesIBA 01/2019
1	Adenosine Monophosphate (AMP)IBA 01/2019
1	Lipase (Acid Lipase)FDA Link 02/2018

Therapy/Procedure

19	Therapeutics 04/2024 - 01/2013
2	Artificial Respiration (Mechanical Ventilation) 12/2022 - 01/2015
1	Phage Therapy 12/2023